Setting the research agenda: involving parents in research on children who are HIV-free.

Authors:
Bukasa LL; Namiba A; Brown M; Ndu'ngu E; Nangwale M and 4 more

Journal:
J Int AIDS Soc

Publication Year: 2023

DOI:
10.1002/jia2.26150

PMCID:
PMC10618900

PMID:
37909217

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Int AIDS Soc

Abbreviation: J Int AIDS Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advanced disease programming brings much needed attention and improvements to inpatient paediatric …
Buck WC; Schindele A; Taibo E and 6 more (2024) - Transparency Score: 3/6
HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender a…
Watson DL; Listerud L; Drab RA and 3 more (2024) - Transparency Score: 3/6
Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowled…
Bromberg DJ; Machavariani E; Madden LM and 8 more (2024) - Transparency Score: 3/6
Long-term retention on antiretroviral treatment after enrolment in prevention of vertical HIV trans…
Urrio RF; Lyatuu GW; Sando D and 14 more (2024) - Transparency Score: 3/6
My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual…
Haberer JE; Oware K; Juma L and 9 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS CT has received funding from ViiV Healthcare via the PENTA Foundation for a pharmacovigilance study on drug use and safety in pregnancy. ST has previously received speaker honoraria and funding for the preparation of educational materials from Gilead Sciences."

Evidence found in paper:

"CT has received funding from ViiV Healthcare via the PENTA Foundation for a pharmacovigilance study on drug use and safety in pregnancy. ST has previously received speaker honoraria and funding for the preparation of educational materials from Gilead Sciences."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025